Immune Thrombocytopenia
Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report
... Immune thrombocytopenia (ITP) is an isolated autoimmune condition, often preceded by a viral infection. Vaccines, mainly the measles-mumps-rubella vaccine, have also been associated with an increased risk ...
7
Immune thrombocytopenia: improving quality of life and patient outcomes
... Therapy thrombocytopenia subscale; FiS, Fatigue impact Score; HRQoL, health-related quality of life; iTP, immune thrombocytopenia; iTP-PAQ, iTP Patient Assessment Questionnaire; Mei-SF, Motivation ...
16
Severe immune thrombocytopenia in chronic lymphocytic leukemia (CLL)
... The ITP evidence was higher in del 11q22-23 positive group- 1 of 12 CLL patients (8.3%) had chromosome 11q22-23 deletion. Cytogenetic 11q chromosome abnormalities have been related to poor outcome (Kalil, and Cheson, ...
5
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
... Abstract: Immune thrombocytopenia (ITP) is an acquired bleeding autoimmune disorder characterized by a markedly decreased blood platelet count. The disorder is variable, frequently having an acute onset of ...
6
Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy
... ITP is a common autoimmune-mediated bleeding disease, in which platelet membrane proteins become antigenic, stimulate the immune system to produce anti- bodies, and eventually result in thrombocytopenia ...
10
Clinical Significance of Positive Platelet Immunofluorescence Assay in Adult Immune Thrombocytopenia: a Cross Sectional Study
... Immune thrombocytopenia (ITP) is a relatively common hematologic disorder manifested by low platelet count due to immune-mediated platelet destruction and/or suppression of platelet ...
8
Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia
... Abstract: Inhibition of platelet production and mediated by antiplatelet antibodies is a well- known mechanism causing low platelet counts in immune thrombocytopenia (ITP). Use of thrombopoietin receptor ...
8
Romiplostim and Eltrombopag for Immune Thrombocytopenia: Methods for Indirect Comparison
... Objectives: Immune thrombocytopenia (ITP) causes increased platelet destruction and suboptimal platelet production, increasing risk of bleeding. This analysis uses a Bayesian metaregression model to ...
10
Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia
... Abstract: Romiplostim is a thrombopoietin receptor agonist (TPO-RA) used for the treatment of adult primary immune thrombocytopenia (ITP). ITP is an autoimmune condition characterized by low platelet counts ...
7
Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy
... Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated ...of thrombocytopenia will extend beyond 12 months consistent with a diagnosis of chronic ...of ...
9
A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review
... severe thrombocytopenia with fist sign in oral cavity within 10 days of starting using ...acyclovir-induced immune thrombocytopenia was established basing on the time correlation between the start of ...
5
Original Article Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia
... Immune thrombocytopenia (ITP) is an autoim- mune disease characterized by low platelet counts with or without mucocutaneous bleed- ing ...of immune system have been shown to play an important role in ...
10
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
... Chronic Immune Thrombocytopenia” was presented at the 2017 meeting of the American Society of Hematology (Tremblay et al, December 2017, accessible at: ...
9
<p>Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease</p>
... of immune thrombocytopenia and the fi rst approved to treat periprocedural thrombocytopenia in patients with chronic liver disease (thereby providing an alternative to blood transfusions for these ...
9
Romiplostim as a treatment for immune thrombocytopenia: a review
... “Immune thrombocytopenia” (ITP) is an autoimmune disorder that leads to peripheral destruction, as well as a decreased production of ...for thrombocytopenia in adults with ...treat ...
8
Clinicopathological Study of Non – Immune Thrombocytopenia
... sepsis-associated thrombocytopenia and hypersplenism ...of thrombocytopenia associated with disordered platelet function are characterized by particularly large giant ...
68
T cell immune abnormalities in immune thrombocytopenia
... Immune thrombocytopenia is an autoimmune disease with abnormal T cell ...cell-mediated immune tolerance to platelet auto-antigens plays a crucial role in immune ...of immune ...
6
Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
... 3. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet produc- tion and ...
5
Romiplostim and Eltrombopag for Immune Thrombocytopenia: Methods for Indirect Comparison
... (idiopathic) thrombocytopenia (ITP) is an autoimmune condition characterised by increased platelet destruction and suboptimal platelet production, resulting in low platelet counts (thrombocytopenia) ...
28
Patient-reported treatment burden of chronic immune thrombocytopenia therapies
... This study was conducted to assess patient perceived and reported treatment side effects, as well as the perceived burden or bother, and need to reduce or stop treatment, associated with[r] ...
8